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Background: Breastfeeding has a major impact on CMV epidemiology. Postnatal CMV reactivation’s incidence
during lactation is nearby the maternal seroprevalence. Although perinatal CMV infection has practically no
consequences in term newborn, it may cause, in some cases, a severe symptomatic disease in preterm newborns.
The aims of the present study are to evaluate the rate and clinical expression of CMV infection breast milk
transmitted in preterm infants and to check the safety of the freezing treated breast milk.
Methods: The study included fifty-seven preterm infants and their CMV seropositive mothers. Fresh breast milk
samples have been collected from 1
st to 9
th postpartum week. Both fresh breast milk and 72, 96, 120 hours frozen
samples have been examined, checking the presence of CMV; urine samples have been tested too.
Results: 70.2% of tested mothers showed reactivation of the infection, and CMV-positive breast milk during the six
weeks postpartum has been found. However, only one infant was infected by CMV, developing hepatic affection
concomitantly with a multi-system involvement, as shown CMV DNA detection in urine, saliva, blood, gastric
aspirate, and stools.
Conclusion: Freezing breast milk at -20°C and pasteurization may respectively reduce or eliminate the viral load.
Background
Human breast milk is considered as an ideal food for
newborns, both for term and preterm infants, because
of its nutritional value, unique qualities and properties.
However it can also be a vehicle for viral and bacterial
infections, as the breastfeeding is known to have a
major impact on the epidemiology of postnatal cytome-
galovirus (CMV) infection [1]. Because of an unknown
mechanism, in women who are positive for anti-CMV
IgG antibodies during breastfeeding viral reactivation
can occur in the mammary glands and CMV may be
generally excreted in the milk without clinical or labora-
tory signs of systemic infection (negative serum IgM,
negative viruria) [2]. In premature and/or low birth
weight (LBW) infants, however, serious consequences
may be brought by breast milk-acquired CMV infection.
At the moment, premature infants who are at risk for
being infected by CMV from breast milk are not guide-
line-filed to be identified [3,4].
The aim of the study is to evaluate the rate and clini-
cal expression of CMV infection transmitted by breast
milk in preterm infants, born before 32 gestational
weeks and/or weighting ≤2000 g at birth, checking the
safety of the freezing treated breast milk.
Methods
Patients
The study has been carried out by Neonatology Intensive
Care Unit (NICU) of the Teaching Hospital, in Perugia
(Italy) from 1
st January 2004 to 31
st December 2007. Fifty
seven preterm infants and their mothers, who were
found CMV seropositive, were included in the prospec-
tive study. The study have been included preterm infants
aged of < 32 complete weeks, or weighting < 2000 g at
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fed by naso-gastric tube (NGT).
Peripheral blood sample has been taken from mothers
after delivery, testing CMV antibodies, to determine
maternal serology. CMV immunoglobulin IgG and IgM
antibodies have been determined, using enzyme immu-
noassay kits (CMV IgG: Diamedix Miami Florida USA,
CMV IgM: Diasorin Saluggia Italy).
Microbiology
Fresh breast milk samples have been collected from the
1th to 9th postpartum week. Fresh breast milk and 72,
96, 120 hours frozen samples have been tested, checking
the presence of CMV. Milk samples have been filed and
separated into cellular and aqueous fractions by centrifu-
gation for obtaining. viral isolation. CMV culture has
been undertaken on aqueous fraction, using the rapid
shell vial tissue culture on MRC-5 cells (Vircell, Santa Fé,
Spain). After two days incubation at 37°C, the cultures
have been tested checking the presence of immediate-
early IE1 and IE2 (MW 68-72 kDa) CMV antigens by
direct immunofluorescence, using FITC-labelled mono-
clonal antibodies (Chemicon Light Diagnostics, Teme-
cula, CA, USA). Milk samples DNA have been extracted
by easyMAG (bioMérieux, Marcy l’Etoile, France) as
molecular tests Nested PCR has been used as screening
test, and quantitative real time PCR (RT-PCR) has been
used to quantify the viral DNA load (Nanogen Advanced
Diagnostics s.r.l., Buttigliera Alta, Torino, Italy). All sam-
ples have been assayed one by one. A negative control
(distilled water) and a positive control (a DNA construct
from CMV genome) have been included in each nested
PCR. The lowest limit of detection was 10 copies/5 μl
and 105 genomes/ml, for nested PCR and RT-PCR,
respectively. Milk has been collected together with urine
samples, to determine the viruria through quantitative
and qualitative methods. Each infant has been fed by
thawed maternal 72 hours frozen breast milk. Clinical
status and laboratory tests have been documented during
the study time. By informed consent, the parents of parti-
cipating infants agreed them to be included in this study.
Results
Milk samples
Previous viral infected mothers have been identified by
IgG seropositivity towards CMV, in absence of IgM. In
40 out of 57 seropositive mothers (70.2%) the virus reac-
tivated and was excreted in the milk during the six
weeks postpartum lactation period. Maternal CMV reac-
tivation was shown by viral shedding in breast milk
(Figure 1) concomitantly with positive serum IgG but
negative IgM, and negative viruria.
There was not statistically significant difference (p = 0.36)
in the values of CMV kinetics, comparing positive samples
to total samples examined in the different weeks. The
majority of the colostrum samples were CMV DNA positive
(31 out of 57, 54.4%) and most milk samples became CMV
DNA positive two weeks after delivery (33 out of 52,
63.5%). During the period of the study 109 samples were
tested and the highest values of CMV DNA copies, ranging
between 10
4 to 10
6 copies/mL, were shown from the 4th to
the 6th week after delivery. In this period the average DNA
Figure 1 CMV DNA kinetics.
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copy number decreased progressively. The 72 h freezing
process was capable of decreasing significantly the infectiv-
ity, as shown by viral culture, and the viral load (by
approximately 75% (Figure 2). However, positive samples
remained positive when tested by PCR, since viral DNA is
detectable, even in the presence of very few inactivated
CMV particles.
Infants
The average gestational age of the newborns was 29
weeks (range 23-34 weeks). The average birth weight
was 1158 ± 436.3 g. Among the infants who have been
fed with CMV DNA-positive breast milk, only one
became infected with CMV. Considering all the checked
women, the rate of postnatal infection in exposed new-
borns was 2.5%: the rate of perinatal infection was 1.7%.
The postnatal rate infection (2.5%) has been considered,
because the infant became CMV positive 8 weeks after
birth and the mother’s serological test did not change,
showing CMV IgM negative and IgG positive. This
results indicate that maternal CMV reactivation was not
systemic but occurred only in the breast.
All the infants were follow e du pt od e t e c tl o n g - t e r m
sequele as described for congenital and perinatal cyto-







month and on 5
th of correct gestation age). To date
(after at least 3 years from the enrolment), none of
them presents health problems correlated with CMV
infection, including the symptomatic infants.
Case report
The infant infected by CMV was born by caesarean
section, carried out in election because of pre-eclampsia
and intrauterine growth retardation, at 28th week and 3
days, having a birth weight of 740 g. He was initially
treated for respiratory distress syndrome and hyperbilir-
ubinaemia. During the first day of life, a wide spectrum
antibiotic therapy as well as Immunoglobulin IgM-
enriched have been administered, because of the
increasing value of C-reactive protein in absence of
other clinical symptoms. However, all tests performed to
detect bacterial infectious were negative: gastric aspira-
tion and tracheobronchial aspiration, including culture
test for Mycoplasma and Clamidia, and blood culture.
Figure 2 Load virus in milk at different time.
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hyperbilirubinaemia, and the liver ultrasound showed
contracted gallbladder in accordance with relevant par-
ietal thickening. On day 47, the clinical condition of the
newborn worsened: elevated serum C-reactive protein
levels were found and the infant was again treated with
multiple antibiotics because of a suspected sepsis, even
if blood and urine cultures were negative. Cholestasis
indexes worsened (Bilirubin total 14,99 mg/dL, Bilirubin
conjugated 8,31 mg/dL, AST 493 U/L, ALT 183 U/L,
GGT 98 U/L). Moreover, the presence of CMV DNA
was evidenced in urine, saliva and blood, and of CMV-
specific IgM antibodies were positive in serum. The
involvement of the digestive system by CMV was con-
firmed by the presence of a high number of viral DNA
copies detected by PCR in the gastric aspirate and
stools. Congenital transmission was excluded by nega-
tive CMV DNA detection from umbilical cord and
Guthrie card, even using highly sensitive real-time PCR.
Clinical improvement occurred in accordance with
intravenous ganciclovir therapy (7,5 mg/Kg/die twice/
day for five days) followed by administration of valganci-
clovir (25 mg/Kg/die for six months) [5]. The viral load
gradually decreased until negativization. Molecular pro-
files of CMV strain isolated from infants’ urine were
indistinguishable from that isolated from maternal
breast milk, indicating vertical CMV transmission
through breast milk.
Discussion
Sepsis- like syndrome in premature infants can be
caused by acquired postnatal CMV infection, as
reported by several studies [4], [6-8]. In order to eluci-
date the role of breastfeeding in transmission of CMV
infection, this study has analysed prospectively both
maternal CMV reactivation during lactation and the
clinical outcome of primary infection of breastfed pre-
term infants. In breast milk whey CMV DNA is detect-
able with more reliability than in unfractionated milk or
milk cells [9-12]. A very high proportion of CMV reacti-
vation in longitudinally screened seropositive mothers
during lactation has been found by RT-PCR, as viral
DNA has been detected in breast milk from 40 out of
57 seropositive mothers (70.17%).
The mechanism of CMV reactivation in human milk,
and the role of milk cells and cell-free virus in vertical
transmission are still unknown [10]. Maternal risk fac-
tors for CMV transmission are considered to be early
excretion of viral DNA and infectious virus in milk
whey. The duration of breastfeeding has been related to
the acquisition of CMV infection by term infants. Viral
load in breast milk has not been correlated to CMV
transmission. Kinetic PCR analysis performed on breast
milk indicated that some samples collected during the
first week after delivery were negative to CMV; viral
DNA became detectable in most of the samples in the
third week, but the copy number increased in the total
samples examined from the 4th to the 6th week and
decreased thereafter. Since the incubation time of
CMV infection is between 30 and 120 days, mother-to-
infant infections transmitt e dv i ab r e a s tm i l ks h o u l dn o t
occur until at least 6 weeks after delivery. However,
more detailed studies are needed to elucidate the
kinetics of CMV reactivation in the milk to reveal
clearly risk factors for transmission. In only one case
CMV DNA was detected in the urine 8 weeks after
delivery. The newborn was not deliveried vaginally,
t h e r e f o r eh em i g h tn o th a v ea c q u i r e dC M Vi n f e c t i o n
from vaginal secretions during the birth process. Ham-
precht et al. have reported that the transmission of
CMV from breastfeeding mothers to their preterm
infants could result in symptomatic CMV infections,
such as sepsis-like disease, and that the early onset of
symptomatic infections occurs only in extremely
immature preterm infants [4,12].
In a previous study, all term infants shed CMV into
urine over a long period, and all of them had normal
clinical courses without sequelae, but two preterm
infants developed pneumonia [13]. Without giving suffi-
cient evidence for breast milk as the maternal source of
postnatal virus transmission, other reports have
described symptomatic cytomegalovirus infection of pre-
term infants with clinical symptoms including neutrope-
nia, thrombocytopenia, hepatosplenomegaly, and
pneumonia [14,15]. In our study, we have observed
CMV transmission in only 1 of 47 (2.5%) preterm
infants, who had clinical symptoms related to CMV
infection (sepsis-like symptoms and hepatosplenome-
galy), although the viral load and detection rate (70.2%)
of CMV DNA in the breast milk were high. The discre-
pancy between our study and other reports may not be
associated with the studied population, since the mean
gestational age and birth weight were similar (29 vs 29
weeks; 1158 vs 1100 g, respectively), rather with the dif-
ference in breast milk storage. In fact, before feeding,
the breast milk has been kept and preserved at -20°C
for 72 hours long care of in our lactarium. Hamprecht
et al. previously have reported that 25% of preterm
infants had acquired CMV infections, after feeding with
raw breast milk refrigerated at 4 to 10°C for a maximum
of 12 hours [10-12]. CMV infections have not been
observed in CMV seronegative preterm infants, fed with
banked human milk which was either pasteurized or fro-
zen [14-17]. However, while detection of CMV after
heating (72°C for 10 seconds) tested negative, freezing
can reduce only partially CMV infectivity, especially
when the virus load was high [18]. This may explain the
occurrence of the transmission of CMV in one infant.
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sion through breast milk can cause a severe clinical
course in preterm infants but freezing could highly
decrease the transmission rate. Because breastfeeding is
healthy and wide spread, and the number of preterm
i n f a n t si si n c r e a s i n gi nt h emost developed countries, a
new procedure for gentle virus inactivation of seroposi-
tive breast milk is being assessed in our laboratory, to
prevent CMV transmission to extremely preterm infants
in the future [19,20].
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